Preliminary results from the use of the novel Interactive Binocular Treatment (I-BiT™) system, in the treatment of strabismic and anisometropic amblyopia

被引:65
|
作者
Waddingham, PE
Butler, TKH
Cobb, SV
Moody, ADR
Comaish, IF
Haworth, SM
Gregson, RM
Ash, IM
Brown, SM
Eastgate, RM
Griffiths, GD
机构
[1] Univ Nottingham, Sch 4M, VIRART, Nottingham NG7 2RD, England
[2] Univ Nottingham Hosp, Queens Med Ctr, Directorate Ophthalmol, Eye Ear Nose & Throat Ctr, Nottingham NG7 2UH, England
关键词
amblyopia; binocular treatment; virtual reality (VR); games;
D O I
10.1038/sj.eye.6701883
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background We have developed a novel application of adapted virtual reality (VR) technology, for the binocular treatment of amblyopia. We describe the use of the system in six children. Methods Subjects consisted of three conventional treatment 'failures' and three conventional treatment 'refusers', with a mean age of 6.25 years ( 5.42 - 7.75 years). Treatment consisted of watching video clips and playing interactive games with specifically designed software to allow streamed binocular image presentation. Results Initial vision in the amblyopic eye ranged from 6/12 to 6/120 and post-treatment 6/7.5 to 6/24-1. Total treatment time was a mean of 4.4 h. Five out of six children have shown an improvement in their vision ( average increase of 10 letters), including those who had previously failed to comply with conventional occlusion. Conclusions Improvements in vision were demonstrable within a short period of time, in some children after 1 h of treatment. This system is an exciting and promising application of VR technology as a new treatment for amblyopia.
引用
收藏
页码:375 / 378
页数:4
相关论文
共 50 条
  • [41] A NOVEL PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL
    Thompson, Eric
    Landi, Daniel
    Archer, Gerald
    Lipp, Eric
    Walter, Ashley
    Archambault, Bridget
    Balajonda, Bea
    Flahiff, Charlene
    Jaggers, Denise
    Herndon, James
    Buckley, Evan
    Schroeder, Kristin
    Randazzo, Dina
    Desjardins, Annick
    Johnson, Margaret
    Peters, Katherine
    Khasraw, Mustafa
    Malinzak, Michael
    Michell, Duane
    Ashley, David
    Sampson, John
    NEURO-ONCOLOGY, 2021, 23 : 46 - 46
  • [42] Preliminary Results of a Novel Side Branch, Access Stent (Antares stent system, TriReme Medical Inc.) for the Treatment of De Novo Coronary Bifurcation Lesions
    Mendes, Alaor
    Ribamar Costa, Ricardo Costa J.
    Staico, Rodolfo
    Mattos, L. Alberto
    Sousa, Amanda
    Abizaid, Andrea Sousa
    Feres, Fausto
    Sousa, J. Eduardo
    Konstantino, Eitean
    Abizaid, Alexandre Cunha
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 186I - 186I
  • [43] Use of biosolids from wastewater treatment plants and other organic fertilizers in agriculture-a preliminary results of a case study in banana cultivation in the Dominican Republic
    Duran, Atuey J. Martinez J.
    Nunez, Vladimir A. Rodriguez A.
    Jaquez, Jose del C. Castillo
    FRONTIERS IN WATER, 2023, 5
  • [44] Cognitive Functioning and Treatment Adherence in Individuals with Comorbid HIV-Infection and Substance Use Disorders: Preliminary Results from the Drug Use and Adherence Life Skills (DUALS) Study
    Smith, Watts A. K.
    Claborn, K. R.
    Ahern, D. C.
    Leavens, E. L.
    CLINICAL NEUROPSYCHOLOGIST, 2017, 31 (04) : 729 - 729
  • [45] Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study
    Advani, Anjali
    Coiffier, Bertrand
    Czuczman, Myron S.
    Dreyling, Martin
    Foran, James
    Gine, Eva
    Gisselbrecht, Christian
    Ketterer, Nicolas
    Nasta, Sunita
    Rohatiner, Ama
    Schmidt-Wolf, Ingo G. H.
    Schuler, Martin
    Sierra, Jorge
    Smith, Mitchell R.
    Verhoef, Gregor
    Winter, Jane N.
    Boni, Joseph
    Vandendries, Erik
    Shapiro, Mark
    Fayad, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (12) : 2085 - 2093
  • [46] EFFICACY AND SAFETY OF THE CRYOBALLOON180 ABLATION SYSTEM FOR THE TREATMENT OF DYSPLASTIC BARRETT'S ESOPHAGUS: PRELIMINARY RESULTS FROM A PROSPECTIVE DUTCH MULTICENTER STUDY
    Munters, Koen
    Frederiks, Charlotte
    Overwater, Anouk
    Pouw, Roos
    Van Munster, Sanne
    Bergman, Jacques
    Weusten, Bas
    GASTROINTESTINAL ENDOSCOPY, 2024, 99 (06) : AB1016 - AB1016
  • [47] Effect of switching from cigarette smoking to the use of the tobacco heating system on periodontitis treatment outcome: Periodontal parameter results from a multicenter Japanese study
    Pouly, Sandrine
    Ng, Wee Teck
    Blanc, Nicolas
    Hession, Paul
    Zanetti, Filippo
    Battey, James N. D.
    de la Bourdonnaye, Guillaume
    Heremans, Annie
    Haziza, Christelle
    FRONTIERS IN DENTAL MEDICINE, 2022, 3
  • [48] Mechanical Embolectomy Using a Novel Telescopic System Featuring a Specialized Delivery and 0.088" Aspiration Catheter for the Treatment of Acute Ischemic Stroke: Preliminary Results of the SUMMIT NZ Trial
    McGuinness, Ben J.
    Caldwell, James
    Barber, P. A.
    Holden, Andrew
    Wu, Teddy Y.
    Krauss, Martin
    Laing, Andrew D.
    Collecutt, Wayne
    Liebeskind, David S.
    Hetts, Steven W.
    Brew, Stefan
    STROKE, 2021, 52
  • [49] FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA Preliminary Results From a Phase I/II Clinical Treatment Trial
    Nti, Akosua A.
    Serrano, Leona W.
    Sandhu, Harpal S.
    Uyhazi, Katherine E.
    Edelstein, Ilaina D.
    Zhou, Elaine J.
    Bowman, Scott
    Song, Delu
    Gangadhar, Tara C.
    Schuchter, Lynn M.
    Mitnick, Sheryl
    Huang, Alexander
    Nichols, Charles W.
    Amaravadi, Ravi K.
    Kim, Benjamin J.
    Aleman, Tomas S.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (03): : 502 - 513
  • [50] Interim results from a phase I/II trial of TPI 287, a novel brain penetrable antimicrotubule agent, in combination with bevacizumab for the treatment of recurrent glioblastoma
    Silberman, Sandra L.
    Goldlust, Samuel
    Nabors, L. Burt
    Duic, J. Paul
    Benkers, Tara
    Mohile, Nimish
    Picker, Donald
    Singer, Samuel
    Farmer, George
    CANCER RESEARCH, 2015, 75